ABVC BioPharma, Inc.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
EFFECT May 20, 2025
DEF 14A May 16, 2025 DEFINITIVE PROXY STATEMENT
POS AM May 16, 2025 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
POS AM May 16, 2025 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
8-K/A May 14, 2025 AMENDMENT TO FORM 8-K
8-K/A May 14, 2025 AMENDMENT NO. 2 TO FORM 8-K
8-K/A May 6, 2025 CURRENT REPORT
8-K/A May 2, 2025 FORM FORM 8-K/A
8-K May 1, 2025 CURRENT REPORT
10-Q Apr 30, 2025 QUARTERLY REPORT
8-K Apr 30, 2025 CURRENT REPORT
PRE 14A Apr 25, 2025 PRELIMINARY PROXY STATEMENT
8-K/A Apr 16, 2025 AMENDMENT NO. 1 TO FORM 8-K
8-K Apr 15, 2025 CURRENT REPORT
10-K Apr 15, 2025 ANNUAL REPORT
NT 10-K Mar 31, 2025 NOTIFICATION OF LATE FILING
8-K Mar 7, 2025 CURRENT REPORT
SCHEDULE 13G/A Feb 14, 2025
8-K/A Jan 13, 2025 AMENDMENT NO. 1 TO FORM 8-K
8-K Jan 6, 2025 CURRENT REPORT
424B4 Nov 15, 2024 PROSPECTUS SUPPLEMENT
424B4 Nov 15, 2024 PROSPECTUS SUPPLEMENT
424B4 Nov 15, 2024 PROSPECTUS SUPPLEMENT
424B4 Nov 15, 2024 PROSPECTUS SUPPLEMENT
SC 13G/A Nov 14, 2024
← Newer Page 3 of 32 · 793 filings Older →